An oral dosage formulation of azacitidine: A pilot pharmacokinetic study No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This ...
Correlative analyses of plasma cytokine/angiogenic factor (C/AF) profile, gender and outcome in a randomized, three-arm, phase II trial of first-line vandetanib (VAN) and/or carboplatin plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results